There is also genetic evidence for the role of TAF1 in cancer, as mutations in TAF1 were implicated as drivers of clear cell endometrial cancer [31], and knockdown of TAF1 resulted in decreased proliferation and self-renewal in leukemia cells expressing a splice variant of the AML1-ETO fusion protein [32]. The gene discussed is TAF1; the disease is endometrial cancer.